Similar articles

• Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.

  Steinberg DH, Mintz GS, Mandinov L, Yu A, Ellis SG, Grube E, Dawkins KD, Ormiston J, Turco MA, Stone GW, Weissman NJ. Steinberg DH, et al. JACC Cardiovasc Interv. 2010 May;3(5):486-94. doi: 10.1016/j.jcin.2010.03.007. JACC Cardiovasc Interv. 2010. PMID: 20488404 Clinical Trial.
• Direct stenting in the DES era: Can we do better?

  Bass TA. Bass TA. Catheter Cardiovasc Interv. 2007 Oct 1;70(4):513-4. doi: 10.1002/ccd.21348. Catheter Cardiovasc Interv. 2007. PMID: 17896409 No abstract available.
• Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.

  Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Martinez EE; PAINT trial investigators. Lemos PA, et al. Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-73. doi: 10.1002/ccd.22166. Catheter Cardiovasc Interv. 2009. PMID: 19670303 Clinical Trial.
• Drug-eluting stent fracture: incidence, contributing factors, and clinical implications.

  Canan T, Lee MS. Canan T, et al. Catheter Cardiovasc Interv. 2010 Feb 1;75(2):237-45. doi: 10.1002/ccd.22212. Catheter Cardiovasc Interv. 2010. PMID: 20025045 Review.
• Myocardial revascularization: surgery or stenting?

  Wong SH, Wan S, Underwood MJ. Wong SH, et al. Asian Cardiovasc Thorac Ann. 2007 Jun;15(3):264-9. doi: 10.1177/021849230701500322. Asian Cardiovasc Thorac Ann. 2007. PMID: 17541004 Review.